Inhibition of the Hypothalamic-Pituitary-Thyroid Axis in Response to Lipopolysaccharide Is Independent of Changes in Circulating Corticosteroids

NeuroImmunoModulation

Volumn 4, Issue 4, 1997, Pages 188-194

  Kondo, Kunikazu ^a   Harbuz, Michael S ^a   Levy, Andrew ^a   Lightman, Stafford L ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Hypothalamic pituitary adrenal axis; Hypothalamic pituitary thyroid axis; Lipopolysaccharide; Sick euthyroid syndrome

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID; LIOTHYRONINE; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROOPIOMELANOCORTIN; PROTIRELIN; THYROTROPIN;

ADRENALECTOMY; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS THYROID SYSTEM; LIOTHYRONINE BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

EID: 13144277614     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097337     Document Type: Article

References (47)

1. Wartofsky L, Burman KD: Alteration in thyroid function in patients with systemic illness: The ‘euthyroid sick syndrome", Endocr Rev 1982;3:164-217.
2. Islcy WL, Underwood LE, Clemmons DRC: Dietary components that regulate serum soma-tomedin-C concentrations in humans, J Clin Invest 1983:71:175-182.
3. Ricu M, Binoux M: Scrum level of insulin-like growth factor (IGF) and IGF binding protein in insulin-dependent diabetes during an episode of severe metabolic decompensation and the recovery phase, J Clin Endocrinol Metab 1985; 60:781-785.
4. Boelen A, Plalvoct-Ter Schiphorst MC, Wiersinga WM: Association between scrum intcr-lcukin-6 and scrum 3.5,3'-triiodothyronine in nonlhyroidal illness, J Clin Endocrinol Metab 1993;77:1695-1699.
5. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M: Transient hypogonadotropic hypogonadism caused by critical illness, J Clin Endocrinol Metab 1985:60:444-450.
6. Bartalcna L, Martino E, Brandi LS, Falcone M, Pacchiarotti A, Ricci C, Bogazzi F, Grasso L, Mammoli C, Pinchcra A: Lack of nocturnal scrum thyrotropin surge after surgen', J Clin Endocrinol Metab 1990:70:293-296.
7. Zaloga GP, Chemow B, Smallridgc RC, Zajt-chuk R, Hall-Boycr K, Hargraves R, Raymond Lake C, Burman KD: A longitudinal evaluation of thyroid function in critically ill surgical patients, Ann Surg 1985;201:456-464.
8. Palwardhan NA, Lombardi A: Effect of tumor necrosis factor on growth and function in FRTL5 cells, Surgery 1991; 110:972-977.
9. Boden A, Plalvoct-Ter Schiphorst MC, Bakkcr O, Wiersinga WM: The role of cytokines in the lipopolysaccharide-induced sick euthyroid syndrome in mice, J Endocrinol 1995:146:475-483.
10. Kakucska I, Romero LI, Clark BD, Rondeel JMM, Qi Y, Alex S, Emerson CH, Lechan RM: Suppression of thyrotropin-releasing hormone gene expression by interleukin-1-beta in the rat: Implications for nonthyroida! illness, Ncu-roendocrinology 1994:59:129-137.
11. Hermus ARMM, Sweep CGJ, Van Der Meer MJM, Alec Ross H, Smals AGH, Benraad TJ, Kloppenborg PWC: Continuous infusion of interleukin-1 u induces a nonlhyroidal illness syndrome in the rat, Endocrinology 1992:131: 2139-2146.
12. Ozawa M, Sato K, Han DC, Kawakami M, Tsushima T, Shizume K: Effects of tumor necrosis factor-a/cachcctin on thyroid hormone metabolism in mice, Endocrinology 1988:123: 1461-1467.
13. Van Der Poll T, Romijn JA, Wiersinga WM, Sauenvein HP: Tumor necrosis factor: A putative mediator of the sick euthyroid syndrome in man, J Clin Endocrinol Mctab 1990:71: 1567-1572.
14. Brabant A, Brabant G, Schuermyer T, Ranft U, Schmidt FW: The role of glucocorticoids in the regulation of thyrotropin, Acta Endocrinol (Co-penh) 1989:121:95-100.
15. Brabant G, Brabant A, Ranft U, Ocran K, Kohrle J, Hcsch R, von zur Muehlen A: Circadian and pulsatile thyrotropin secretion in euthyroid man under the influence of thyroid hormone and glucocorticoid administration, J Clin Endocrinol Metab 1987:65:83-88.
16. Re RN, Kourides IA, Ridgway EC, Wcintraub BD, Maloof F: The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin, J Clin Endocrinol Mctab 1976:43:338-346.
17. Sowers JR., Carlson HE, Brautbar N, Hersh-man JM: Effect of dcxamcthasonc on prolactin and TSH responses toTRH and metoclopram-ide in man, J Clin Endocrinol Metab 1977:44: 237-241.
18. Otsuki M, Dakoda M, Baba S: Influence of glucocorticoids on TRF-induced TSI1 response in man, J Clin Endocrinol Metab 1973:36:95-102.
19. Kakucska I, Qi Y, Lechan RM: Changes in adrenal status affect hypothalamic thyrotropin-releasing hormone gene expression in parallel with corticotropin-releasing hormone, Endocrinology 1995:136:2795-2802.
20. Tibaldi JM, Surks MI: Animal model of nonthyroidal disease, Endocr Rev 1985:6:87-102.
21. Dyer RG, Wciek RF, Mansfield S, Corbet H: Secretion of luteinizing hormone in ovariecto-mized adult rats treated neonatally with monosodium glutamate, J Endocrinol 1981:91: 341-346.
22. Shi ZX, Levy A, Lightman SL: Thyroid hormone-mediated regulation of corticotropin-releasing hormone messenger ribonucleic acid in the rat, Endocrinology 1994;134:1577-1580.
23. Faber J, Francis Thomsen H, Lumholtz IB, Kirkegaard C, Siersbaek-Nielsen K, Friis T: Kinetic studies of thyroxine 3.5.3'-triiodothy-ronine, 3.3'.5'-triiodothyroninc, 3'.5'-diiodo-thyronine, 3.3'-diiodothyronine, and 3’-mono-iodothvronine in patients with liver cirrhosis, J Clin Endocrinol Metab 1981;53:978-984.
24. Kaptein EM, Robinson WJ, Gricb DA, Nico-lol TJT: Peripheral scrum thyroxine, triiodothyronine, and reverse triiodothyronine kinetics in the low thyroxine state of acute nonthyroidal illnesses, J Clin Invest 1982:69:526-535.
25. Chopra IJ, Huang T-S, Solomon DH, Chaud-huri G, Chua Teco GN: The role of thyroxine (T4)-binding scrum proteins in oleic acid-in-duccd increase in free T4 in nonthyroidal illness, J Clin Endocrinol Mctab 1986:63:776-779.
26. Haynes IG, Lockett SJ, Farmer MJ: Is oleic acid the thyroxine binding inhibitor in the serum of ill patients? Clin Endocrinol 0x0 1989:31:25-30.
27. Krulich L: Neurotransmitter control of thyrotropin secretion, Neuroendocrinology 1982:35: 139-147.
28. Lamberts SWJ, Zuydcrwijk J, den Holder F, van Koetsvcld P, Holland L: Studies on the conditions determining the inhibitory effect of somatostatin on adrcnocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells, Neuroendocrinology 1989:50:44-50.
29. Topliss DJ, White EL, Stoekigt JR.: Significance of thyrotropin excess in untreated primary adrenal insufficiency, J Clin Endocrinol Melab 1980:50:52-56.
30. Gonzalez JJ, Werk EE Jr.: Abnormal thyrotropin and prolactin level in untreated corticotropin deficiency, Arch Intern Med 1985:145: 356-357.
31. Benker G, Raida M, Olbrichl T, Wagner R, Reinhardt W, Reinwein D: TSH secretion in Cushing’s syndrome: Relation to glucocorticoid excess, diabetes, goitre, and the ‘sick euthyroid syndrome', Clin Endocrinol 0x0 1990:33:777-786.
32. Lee SL, Stewart K, Goodman H: Structure of the gene encoding rat thyrotropin releasing hormone, J Biol Client 1988:263:16604-16609.
33. Cintra A, Fuxc K, Wikstrocm AC, Visser T, Gustafsson JA: Evidence for thyrotropin-re-leasing hormone and glucocorticoid rcceptor-immunoreactive neurons in various preoptic and hypothalamic nuclei of the male rat, Brain Res 1990:506:139-144.
34. Enomoto T, Sugawa H, Kosugi S, Inouc D, Mori T, Imura H: Prolonged effects of recombinant human intcrlcukin-la on mouse thyroid function, Endocrinology 1990;127:2322-2327.
35. Van Haastercn GAC, Van Der Meer MJM, Hermus ARMM, Linkeis E, Klootwijk W, Kap-lein E, Van Toor H, Sweep CGJ, Visser TJ, Dc GrcefWJ: Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hvpothalamic-hypophysial-thyroid axis, Endocrinology 1994:135:1336-1345.
36. Bartalena L, Grasso L, Brogioni S, Martino H: Interleukin 6 effects on the pituitary-thyroid axis in the rat, EurJ Endocrinol 1994:131:302-306.
37. Boelen A, Platvoet-Ter Schiphorst MC, Wier-singa WM: Soluble cytokine receptors and the low 3,5,3'-triiodothyroninc syndrome in patients with nonthyroidal disease, J Clin Endocrinol Melab 1995:80:971-976.
38. Lim C-F, Docter R, Visser TJ, Krcnning EP, Bernard B, Van Toor H, Dc Jong M, Henne-rnann G: Inhibition of thyroxine transport into cultured rat hepatocvtes by serum of nonur-cmic critically ill patients: Effects of bilirubin and nonestcrified fatty acids, J Clin Endocrinol Mctab 1993;76:1165-1172.
39. Judd AM, Hedge GA: The roles of the opioid peptides in controlling thyroid stimulating hormone release, Life Sci 1982:31:2529-2536.
40. Lightman SL, Harbuz MS, Knight RA, Chow-drey HS: CRF mRNA in normal and stress condition, Ann NY Acad Sci 1993:697:28-38.
41. Dubuis J-M, Dayer J-M, Siegrist-Kaiser CA, Burger AG: Human recombinant intcrleukin-I ß decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats, Endocrinology 1988:123:2175-2181.
42. Bemton EW, Beach JE, Holaday JW, Srnall-ridge RC, Fein HG: Release of multiple hormones by a direct action of interleukin-1 on pituitary cells, Science 1987;238:519-521.
43. Bescdovsky H, Del Ray A, Sorkin E, Dinarello CA: Immunorcgulatory feedback between interleukin-1 and glucocorticoid hormones, Science 1986:233:652-654.
44. Woloski BMRNJ, Smith EM, Meyer WJ III, Fuller GM, Blalock JE: Corticotropin-releasing activity of monokines, Science 1985:230: 1035-1037.
45. Harbuz MS, Slephanou A, Sarlis N, Lightman SL: The effects of recombinant interleukin (IL)-la, IL-Iß or IL-6 on hypothalamo-pitu-itary-adrcnal axis activation, J Endocrinol 1992.133:349-355.
46. Doherty GM, Lange JR., Langstein HN, Richard Alexander H, Buresh CM, Norton JA: Evidence for IFN-y asa mediator of the lethality of endotoxin and tumor necrosis factor-u, J Immunol 1992:149:1666-1670.
47. Harbuz MS, Lightman SL: Stress and the hypo-thalamo-pituitary-adrcnal axis: Acute, chronic and immunological activation, J Endocrinol 1992:134:327-339.